Stay updated on Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Sign up to get notified when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.

Latest updates to the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page
- Check7 days agoChange DetectedA site-wide notice about a funding lapse and NIH Clinical Center operating status was added, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check14 days agoChange DetectedUI improvements include a glossary toggle and color-coded change highlights, and the footer revision text was updated from v3.3.4 to v3.4.0 with the No FEAR Act Data element removed.SummaryDifference0.7%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a new revision entry (v3.3.4) to the history, and removed the previous revision reference (v3.3.3), indicating a small metadata update to the page history.SummaryDifference0.1%

- Check49 days agoChange DetectedFooter area updated to include Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2 (Revision: v3.3.2 added; Revision: v3.2.0 removed). This is a small, non-substantive update to the page's revision history display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRemoved a general site notice about government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.